Sector revisions Takeda Pharmaceutical Company Limited

Stocks

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-07-17 EDT			5-day change	1st Jan Change
5,480.00 ^JPY	+2.53%		+2.26%	+13.34%

07-17	Asian Equities Traded in the US as American Depositary Receipts Fall in Friday Trading	MT
07-17	Takeda Pharmaceutical Reports Positive Phase 3 Data for Zasocitinib in Moderate-to-Severe Plaque Psoriasis	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							22
	ABBVIE INC.							28
	ROCHE HOLDING AG							18
	NOVARTIS AG							21
	ASTRAZENECA PLC							22
	NOVO NORDISK A/S							24
	AMGEN INC.							29
	GILEAD SCIENCES, INC.							27
	PFIZER INC.							26
	BRISTOL-MYERS SQUIBB COMPANY							24
	VERTEX PHARMACEUTICALS INCORPORATED							23
	SANOFI							23
	GSK PLC							20
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	BAYER AG							18
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							15
	HALEON PLC							17
	TEVA PHARMACEUTICAL INDUSTRIES LIMITED							10
	Average							21
	Weighted average by Cap.							24